OMERS Administration Corp’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $70.4M | Sell |
547,569
-1,051,358
| -66% | -$123M | 0.42% | 46 |
|
|
2026
Q1 | $192M | Buy |
1,598,927
+1,323,314
| +480% | +$153M | 1.24% | 16 |
|
|
2025
Q4 | $29M | Sell |
275,613
-2,361
| -0.8% | -$222K | 0.21% | 61 |
|
|
2025
Q3 | $23.3M | Buy |
277,974
+7,129
| +3% | +$587K | 0.17% | 64 |
|
|
2025
Q2 | $21.4M | Buy |
270,845
+13,764
| +5% | +$1.09M | 0.17% | 64 |
|
|
2025
Q1 | $23.1M | Buy |
257,081
+26,900
| +12% | +$2.51M | 0.2% | 59 |
|
|
2024
Q4 | $22.9M | Buy |
230,181
+31,657
| +16% | +$3.26M | 0.2% | 59 |
|
|
2024
Q3 | $22.5M | Buy |
198,524
+15,964
| +9% | +$1.9M | 0.21% | 61 |
|
|
2024
Q2 | $22.6M | Buy |
182,560
+157,453
| +627% | +$20.3M | 0.22% | 57 |
|
|
2024
Q1 | $3.31M | Sell |
25,107
-103,141
| -80% | -$12.7M | 0.04% | 109 |
|
|
2023
Q4 | $14M | Hold |
128,248
| – | – | 0.18% | 56 |
|
|
2023
Q3 | $13.2M | Buy |
128,248
+76,405
| +147% | +$8.24M | 0.2% | 52 |
|
|
2023
Q2 | $5.98M | Sell |
51,843
-10,706
| -17% | -$1.22M | 0.09% | 75 |
|
|
2023
Q1 | $6.65M | Sell |
62,549
-21,693
| -26% | -$2.34M | 0.1% | 72 |
|
|
2022
Q4 | $9.35M | Buy |
84,242
+43,096
| +105% | +$4.41M | 0.15% | 66 |
|
|
2022
Q3 | $3.54M | Buy |
+41,146
| New | +$3.67M | 0.06% | 80 |
|
|
2020
Q1 | – | Sell |
-146,720
| Closed | -$12.7M | – | 312 |
|
|
2019
Q4 | $12.7M | Sell |
146,720
-13,519
| -8% | -$1.11M | 0.15% | 72 |
|
|
2019
Q3 | $12.9M | Buy |
160,239
+39,300
| +32% | +$3.15M | 0.13% | 77 |
|
|
2019
Q2 | $9.81M | Buy |
120,939
+108,468
| +870% | +$8.31M | 0.1% | 84 |
|
|
2019
Q1 | $1.03M | Buy |
+12,471
| New | +$933K | 0.01% | 215 |
|
|
2018
Q2 | – | Sell |
-130,476
| Closed | -$6.78M | – | 452 |
|
|
2018
Q1 | $6.78M | Buy |
130,476
+7,126
| +6% | +$385K | 0.07% | 112 |
|
|
2017
Q4 | $6.62M | Buy |
123,350
+60,575
| +96% | +$3.36M | 0.07% | 115 |
|
|
2017
Q3 | $3.83M | Buy |
62,775
+38,147
| +155% | +$2.31M | 0.04% | 174 |
|
|
2017
Q2 | $1.51M | Buy |
+24,628
| New | +$1.5M | 0.02% | 276 |
|
|
2017
Q1 | – | Sell |
-541,910
| Closed | -$30.4M | – | 364 |
|
|
2016
Q4 | $30.4M | Sell |
541,910
-397,821
| -42% | -$23.3M | 0.57% | 49 |
|
|
2016
Q3 | $56M | Sell |
939,731
-121,159
| -11% | -$7.09M | 1% | 31 |
|
|
2016
Q2 | $58.3M | Sell |
1,060,890
-279,764
| -21% | -$14.9M | 1.2% | 28 |
|
|
2016
Q1 | $67.7M | Buy |
+1,340,654
| New | +$65.7M | 1.5% | 23 |
|
|
2014
Q1 | – | Sell |
-1,240,832
| Closed | -$59.3M | – | 390 |
|
|
2013
Q4 | $59.3M | Buy |
1,240,832
+918,153
| +285% | +$42M | 2.18% | 16 |
|
|
2013
Q3 | $14.7M | Hold |
322,679
| – | – | 1.39% | 21 |
|
|
2013
Q2 | $14.3M | Buy |
+322,679
| New | +$14.4M | 1.33% | 23 |
|
Other funds holding MRK
OMERS Administration Corp's MRK Position: Q2 2026 in Review
OMERS Administration Corp reduced its Merck (MRK) stake by 66% in Q2 2026, selling an estimated $123M and leaving 547,569 shares worth $70.4M. The position accounts for 0.42% of the portfolio, ranked #46.
OMERS Administration Corp first reported a position in MRK in Q2 2013 and has held it in 31 quarters since. The position peaked at $192M in Q1 2026. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- OMERS Administration Corp held 547,569 shares of Merck worth $70.4M as of Q2 2026.
- OMERS Administration Corp sold 1,051,358 Merck shares in Q2 2026, an estimated $123M.
- Merck made up 0.42% of OMERS Administration Corp's portfolio in Q2 2026, its #46 holding.
- OMERS Administration Corp first reported a position in Merck in Q2 2013 and has held it in 31 quarters since.
- OMERS Administration Corp's Merck position peaked at $192M in Q1 2026.
- 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.